Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Equity Ratio (2020 - 2025)

Oncology Institute's Equity Ratio history spans 6 years, with the latest figure at 0.1 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 559.45% year-over-year to 0.1; the TTM value through Dec 2025 reached 0.1, down 559.45%, while the annual FY2025 figure was 0.1, 559.45% down from the prior year.
  • Equity Ratio reached 0.1 in Q4 2025 per TOI's latest filing, down from 0.08 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.65 in Q2 2022 to a low of 0.1 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.25, with a median of 0.21 recorded in 2021.
  • Peak YoY movement for Equity Ratio: soared 364.83% in 2021, then tumbled 559.45% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.51 in 2021, then fell by 8.06% to 0.47 in 2022, then tumbled by 42.1% to 0.27 in 2023, then tumbled by 92.38% to 0.02 in 2024, then plummeted by 559.45% to 0.1 in 2025.
  • Per Business Quant, the three most recent readings for TOI's Equity Ratio are 0.1 (Q4 2025), 0.08 (Q3 2025), and 0.06 (Q2 2025).